XML 38 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash provided by (used in) operating activities:      
Net income (loss) $ (430.3) $ (5.4) $ 211.6
Adjustments to reconcile net income (loss) to cash provided by operating activities:      
Depreciation and amortization 108.3 122.8 108.8
Non cash operating lease costs 19.1 18.6 16.1
Deferred income taxes (121.4) (44.7) (5.0)
Disposal/impairment of assets 1.3 4.3 2.5
Restructuring and other (income) charges, net 186.2 170.2 13.8
CTO resales 52.7 22.0 0.0
LIFO reserve (18.7) 72.9 10.0
Share-based compensation 11.9 10.6 16.1
(Gain) loss on strategic investment 11.4 (19.3) 0.0
Pension and other postretirement benefit costs 1.5 1.6 1.4
Goodwill impairment charge 349.1 0.0 0.0
Other non-cash items 17.0 36.2 18.4
Changes in operating assets and liabilities, net of effect of acquisitions:      
Accounts receivable, net 38.2 42.7 (42.1)
Inventories, net 86.2 (75.6) (63.7)
Prepaid and other current assets 7.7 (28.6) (0.8)
Planned major maintenance outage (6.5) (12.8) (9.1)
Accounts payable (63.4) (14.6) 42.7
Accrued expenses (1.0) (7.7) 0.8
Accrued payroll and employee benefits 8.0 (33.5) 5.4
Income taxes (13.8) 6.4 4.9
Operating leases (21.7) (22.5) (18.8)
Restructuring and other spending (59.3) (44.0) (13.8)
CTO resales (46.1) (10.6) 0.0
Changes in all other operating assets and liabilities, net 12.2 16.1 14.2
Net cash provided by (used in) operating activities 128.6 205.1 313.4
Cash provided by (used in) investing activities:      
Capital expenditures (77.6) (109.8) (142.5)
Payments for acquired businesses, net of cash acquired 0.0 0.0 (344.5)
Proceeds from sale of strategic investment 0.0 31.5 0.0
Net investment hedge settlement 0.0 0.0 14.7
Purchase of strategic investments (0.3) (2.4) (77.4)
Other investing activities, net (1.6) 3.4 (2.2)
Net cash provided by (used in) investing activities (79.5) (77.3) (551.9)
Cash provided by (used in) financing activities:      
Proceeds from revolving credit facility and other borrowings 404.5 376.3 1,164.7
Payments on revolving credit facility and other borrowings (470.6) (382.9) (336.7)
Payments on long-term borrowings 0.0 0.0 (628.1)
Debt issuance costs 0.0 (0.4) (3.0)
Debt repayment costs 0.0 0.0 (3.8)
Financing lease obligations, net (1.0) (0.7) (0.9)
Tax payments related to withholdings on vested equity awards (3.1) (4.8) (2.2)
Proceeds and withholdings from share-based compensation plans, net 0.0 4.7 4.1
Repurchases of common stock under publicly announced plan 0.0 (92.1) (145.2)
Other financing activities, net 0.0 0.0 (0.8)
Net cash provided by (used in) financing activities (70.2) (99.9) 48.1
Increase (decrease) in cash, cash equivalents, and restricted cash (21.1) 27.9 (190.4)
Effect of exchange rate changes on cash (4.2) (0.3) (6.0)
Change in cash, cash equivalents, and restricted cash (25.3) 27.6 (196.4)
Cash, cash equivalents, and restricted cash at beginning of period [1] 111.9 84.3 280.7
Cash, cash equivalents, and restricted cash at end of period [1] 86.6 111.9 84.3
Supplemental cash flow information:      
Cash paid for interest, net of capitalized interest 85.4 82.7 54.8
Cash paid for income taxes, net of refunds 26.9 29.7 54.8
Purchases of property, plant, and equipment in accounts payable 2.4 2.8 4.9
Leased assets obtained in exchange for new finance lease liabilities 0.0 0.2 0.0
Leased assets obtained in exchange for new operating lease liabilities $ 6.0 $ 29.1 $ 23.7
[1]
(1) Includes restricted cash of $18.6 million, $16.0 million, and $7.6 million and cash and cash equivalents of $68.0 million, $95.9 million, and $76.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. Restricted cash is included within "Prepaid and other current assets" and "Restricted investment" within the consolidated balance sheets.